rs34788341
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4
The NM_024312.5(GNPTAB):c.3335+6T>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000109 in 1,343,364 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_024312.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNPTAB | NM_024312.5 | c.3335+6T>G | splice_region_variant, intron_variant | ENST00000299314.12 | NP_077288.2 | |||
GNPTAB | XM_011538731.3 | c.3254+6T>G | splice_region_variant, intron_variant | XP_011537033.1 | ||||
GNPTAB | XM_006719593.4 | c.3335+6T>G | splice_region_variant, intron_variant | XP_006719656.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNPTAB | ENST00000299314.12 | c.3335+6T>G | splice_region_variant, intron_variant | 1 | NM_024312.5 | ENSP00000299314.7 | ||||
GNPTAB | ENST00000550718.1 | c.146+6T>G | splice_region_variant, intron_variant | 3 | ENSP00000449557.1 | |||||
GNPTAB | ENST00000549194.1 | n.201+6T>G | splice_region_variant, intron_variant | 3 | ||||||
GNPTAB | ENST00000549738.5 | n.86+6T>G | splice_region_variant, intron_variant | 4 | ENSP00000450161.1 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151864Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251120Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135772
GnomAD4 exome AF: 0.000117 AC: 140AN: 1191500Hom.: 0 Cov.: 18 AF XY: 0.000120 AC XY: 73AN XY: 606416
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151864Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74220
ClinVar
Submissions by phenotype
Pseudo-Hurler polydystrophy;C2673377:Mucolipidosis type II Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 25, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change falls in intron 17 of the GNPTAB gene. It does not directly change the encoded amino acid sequence of the GNPTAB protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs34788341, gnomAD 0.01%). This variant has been observed in individual(s) with mucolipdosis III alpha/beta (PMID: 16465621, 19617216). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as IVS17+6T>G. ClinVar contains an entry for this variant (Variation ID: 2773). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 17 and introduces a premature termination codon (PMID: 16465621). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Jan 11, 2017 | - - |
Mucolipidosis type II Pathogenic:2Other:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | - | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pseudo-Hurler polydystrophy Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2006 | - - |
Mucopolysaccharidosis, MPS-III-A Pathogenic:1
Pathogenic, no assertion criteria provided | curation | GeneReviews | May 10, 2012 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 14, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at